Amgen CFO talks Q2 earnings, obesity drug, and growth

(7:18)

Amgen partners with China's BeiGene on cancer drug research

(1:24)

Cramer’s Mad Dash: Amgen

(1:5)

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

(3:11)

Amgen has 'a lot to prove' in the weight-loss drug category, says Mizuho's Jared Holz

(5:5)

Amgen to buy Horizon Therapeutics, U.S. to announce nuclear breakthrough and more

(1:42)

Amgen's Commitment to ESG

(45:46)

Wait for longer-term data with Amgen's GLP-1, says Piper Sandler's Christopher Raymond

(3:42)

CHCH Evening News at 11

(29:53)

Biotechnology and Healthcare: A New Dawn? CEO Bob Bradway on Money Maze Podcast

(35:47)

Taking a Closer Look at Volatility PLUS Dogs of the Dow 2025! | Market \u0026 Sector Analysis

(44:31)

Nobel Prize winner raises concerns about AI

(2:34)

Amgen: Are Its Golden Days Over? | FAST Graphs

(29:4)

US: California-based firm Amgen developed Nplate drug, cures radiation sicknes | Latest News | WION

(4:41)

The Problem with Nuclear Fusion

(17:4)

The Challenges in Manufacturing Biologics

(5:9)

Mesoblast prepares to launch FDA-approved therapy for Pediatric Steroid-Refractory aGVHD

(8:40)

Amgen Said to Agree to $26 Billion Purchase of Horizon

(55)

Amgen has great science, but they don't seem to make it across the finish line, says Jim Cramer

(2:7)

Amgen breaks ground on $200M 'next-generation' plant in RI

(1:48)

FTC sues to block Amgen acquisition of Horizon Therapeutics

(1:15)

Jefferies' Michael Yee still likes Amgen in the biotech sector

(3:33)

Dr. Gottlieb on Amgen's new weight loss drug: Expect to be on par with Wegovy \u0026 Mounjaro or better

(7:56)

Bob Bradway: How Amgen is using AI to better understand disease

(17)

Jefferies' Michael Yee expects Amgen's Horizon Therapeutics deal will go through despite FTC block

(4:31)

Horizon Therapeutics in preliminary sale talks with Amgen, Sanofi, J\u0026J

(2:57)

Amgen beats EPS and revenue, $6.42B vs. $6.38B, raises full-year guidance

(38)